CA Stock MarketDetailed Quotes

WBIO WPD Pharmaceuticals Inc

Watchlist

0.010
-0.010-50.00%

15min DelayMarket Closed Dec 24 11:24 ET

1.16MMarket Cap0.00P/E (TTM)

WPD Pharmaceuticals Inc Key Stats

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-23.92%50.29K

10.36%88.85K

269.08%140.14K

-92.47%66.11K

-89.22%80.51K

-93.86%37.97K

2.33M

85.68K

-27.31%878.04K

-45.26%746.9K

Selling and administrative expenses

-25.33%46.52K

7.66%78.65K

198.55%93.3K

-92.72%62.3K

-89.93%73.06K

-94.56%31.25K

--2.21M

--52.23K

9.68%855.19K

5.72%725.45K

-General and administrative expense

-25.33%46.52K

7.66%78.65K

198.55%93.3K

-92.72%62.3K

-89.93%73.06K

-94.56%31.25K

--2.21M

--52.23K

12.94%855.19K

7.17%725.45K

Depreciation amortization depletion

-22.86%2.71K

--2.71K

-58.87%3.51K

--0

--24.44K

--6.24K

-90.70%8.53K

-93.74%5.54K

-Depreciation and amortization

-22.86%2.71K

--2.71K

-58.87%3.51K

--0

--24.44K

--6.24K

-90.70%8.53K

-93.74%5.54K

Other taxes

----

--18.78K

--3.23K

-94.12%2.96K

-88.34%2.42K

Other operating expenses

257.00%1.07K

0.55%7.49K

556.92%44.13K

-97.36%300

-44.78%7.45K

-77.59%6.72K

--78.81K

--23.97K

-90.99%11.36K

-68.89%13.5K

Operating profit

23.92%-50.29K

-10.36%-88.85K

-269.08%-140.14K

92.47%-66.11K

89.22%-80.51K

93.86%-37.97K

-2.33M

-85.68K

27.31%-878.04K

45.26%-746.9K

Net non-operating interest income (expenses)

5.23%-16.89K

-222.54%-16.1K

-15.37K

63.09%-17.83K

89.63%-4.99K

-167.52K

-30.15K

-581.01%-48.3K

-4,964.00%-48.11K

Non-operating interest expense

-5.23%16.89K

222.54%16.1K

--15.37K

-63.09%17.83K

-89.63%4.99K

--0

--167.52K

--30.15K

581.01%48.3K

4,964.00%48.11K

Other net income (expenses)

6,080.71%114.71K

1,155.08%85.95K

-2.11K

-1,926.67%-1.92K

137.71%6.85K

6.35M

6.28M

-99.98%105

-112.96%-18.16K

Gain on sale of security

740.51%12.29K

-113.01%-891

---2.11K

77.85%-1.92K

83.25%6.85K

----

---11.51K

--12.67K

-5,486.45%-8.66K

315.39%3.74K

Special income (charges)

--102.43K

--86.84K

----

--0

----

---30.1K

---11.83K

--3.11K

---21.01K

-Less:Impairment of capital assets

----

--30.1K

--11.83K

---3.11K

--21.01K

-Less:Other special charges

---102.43K

---86.84K

----

-Less:Write off

----

--0

----

Other non-operating income (expenses)

----

--1.87M

--1.76M

-98.89%5.66K

-100.63%-887

Income before tax

155.36%47.52K

75.84%-19K

-315.11%-157.62K

90.73%-85.85K

90.33%-78.65K

93.36%-37.97K

3.86M

6.17M

-30.89%-926.23K

33.63%-813.17K

Income tax

Earnings from equity interest net of tax

Net income

155.36%47.52K

75.84%-19K

-315.11%-157.62K

90.73%-85.85K

90.33%-78.65K

93.36%-37.97K

3.86M

6.17M

-30.89%-926.23K

33.63%-813.17K

Net income continuous operations

155.36%47.52K

75.84%-19K

-315.11%-157.62K

90.73%-85.85K

90.33%-78.65K

93.36%-37.97K

--3.86M

--6.17M

-30.89%-926.23K

33.63%-813.17K

Noncontrolling interests

Net income attributable to the company

155.36%47.52K

75.84%-19K

-315.11%-157.62K

90.73%-85.85K

90.33%-78.65K

93.36%-37.97K

3.86M

6.17M

-30.89%-926.23K

33.63%-813.17K

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

155.36%47.52K

75.84%-19K

-315.11%-157.62K

90.73%-85.85K

90.33%-78.65K

93.36%-37.97K

3.86M

6.17M

-30.89%-926.23K

33.63%-813.17K

Diluted earnings per share

75.90%-0.0002

-314.63%-0.0014

93.07%-0.0007

96.65%-0.0003

0.03

0.05

0.00%-0.01

Basic earnings per share

75.90%-0.0002

-314.63%-0.0014

93.07%-0.0007

96.65%-0.0003

0.03

0.05

0.00%-0.01

Dividend per share

Accounting Standards

US-GAAP

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-23.92%50.29K	10.36%88.85K	269.08%140.14K	-92.47%66.11K	-89.22%80.51K	-93.86%37.97K	2.33M	85.68K	-27.31%878.04K	-45.26%746.9K
Selling and administrative expenses	-25.33%46.52K	7.66%78.65K	198.55%93.3K	-92.72%62.3K	-89.93%73.06K	-94.56%31.25K	--2.21M	--52.23K	9.68%855.19K	5.72%725.45K
-General and administrative expense	-25.33%46.52K	7.66%78.65K	198.55%93.3K	-92.72%62.3K	-89.93%73.06K	-94.56%31.25K	--2.21M	--52.23K	12.94%855.19K	7.17%725.45K
Depreciation amortization depletion	-22.86%2.71K	--2.71K	--2.71K	-58.87%3.51K	--0	--0	--24.44K	--6.24K	-90.70%8.53K	-93.74%5.54K
-Depreciation and amortization	-22.86%2.71K	--2.71K	--2.71K	-58.87%3.51K	--0	--0	--24.44K	--6.24K	-90.70%8.53K	-93.74%5.54K
Other taxes	----	----	----	----	----	----	--18.78K	--3.23K	-94.12%2.96K	-88.34%2.42K
Other operating expenses	257.00%1.07K	0.55%7.49K	556.92%44.13K	-97.36%300	-44.78%7.45K	-77.59%6.72K	--78.81K	--23.97K	-90.99%11.36K	-68.89%13.5K
Operating profit	23.92%-50.29K	-10.36%-88.85K	-269.08%-140.14K	92.47%-66.11K	89.22%-80.51K	93.86%-37.97K	-2.33M	-85.68K	27.31%-878.04K	45.26%-746.9K
Net non-operating interest income (expenses)	5.23%-16.89K	-222.54%-16.1K	-15.37K	63.09%-17.83K	89.63%-4.99K	0	-167.52K	-30.15K	-581.01%-48.3K	-4,964.00%-48.11K
Non-operating interest expense	-5.23%16.89K	222.54%16.1K	--15.37K	-63.09%17.83K	-89.63%4.99K	--0	--167.52K	--30.15K	581.01%48.3K	4,964.00%48.11K
Other net income (expenses)	6,080.71%114.71K	1,155.08%85.95K	-2.11K	-1,926.67%-1.92K	137.71%6.85K		6.35M	6.28M	-99.98%105	-112.96%-18.16K
Gain on sale of security	740.51%12.29K	-113.01%-891	---2.11K	77.85%-1.92K	83.25%6.85K	----	---11.51K	--12.67K	-5,486.45%-8.66K	315.39%3.74K
Special income (charges)	--102.43K	--86.84K	----	--0	--0	----	---30.1K	---11.83K	--3.11K	---21.01K
-Less:Impairment of capital assets	----	----	----	----	----	----	--30.1K	--11.83K	---3.11K	--21.01K
-Less:Other special charges	---102.43K	---86.84K	----	----	----	----	----	----	----	----
-Less:Write off	----	----	----	----	----	----	--0	----	----	----
Other non-operating income (expenses)	----	----	----	----	----	----	--1.87M	--1.76M	-98.89%5.66K	-100.63%-887
Income before tax	155.36%47.52K	75.84%-19K	-315.11%-157.62K	90.73%-85.85K	90.33%-78.65K	93.36%-37.97K	3.86M	6.17M	-30.89%-926.23K	33.63%-813.17K
Income tax
Earnings from equity interest net of tax
Net income	155.36%47.52K	75.84%-19K	-315.11%-157.62K	90.73%-85.85K	90.33%-78.65K	93.36%-37.97K	3.86M	6.17M	-30.89%-926.23K	33.63%-813.17K
Net income continuous operations	155.36%47.52K	75.84%-19K	-315.11%-157.62K	90.73%-85.85K	90.33%-78.65K	93.36%-37.97K	--3.86M	--6.17M	-30.89%-926.23K	33.63%-813.17K
Noncontrolling interests
Net income attributable to the company	155.36%47.52K	75.84%-19K	-315.11%-157.62K	90.73%-85.85K	90.33%-78.65K	93.36%-37.97K	3.86M	6.17M	-30.89%-926.23K	33.63%-813.17K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders	155.36%47.52K	75.84%-19K	-315.11%-157.62K	90.73%-85.85K	90.33%-78.65K	93.36%-37.97K	3.86M	6.17M	-30.89%-926.23K	33.63%-813.17K
Diluted earnings per share	0	75.90%-0.0002	-314.63%-0.0014	0	93.07%-0.0007	96.65%-0.0003	0.03	0.05	0.00%-0.01	0.00%-0.01
Basic earnings per share	0	75.90%-0.0002	-314.63%-0.0014	0	93.07%-0.0007	96.65%-0.0003	0.03	0.05	0.00%-0.01	0.00%-0.01
Dividend per share
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List

Overall

No Data

WBIO WPD Pharmaceuticals Inc

WPD Pharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow